AlphaQuest LLC raised its holdings in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 278.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,059 shares of the electronics maker’s stock after acquiring an additional 30,199 shares during the period. AlphaQuest LLC’s holdings in Dolby Laboratories were worth $2,637,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the business. Hantz Financial Services Inc. raised its stake in Dolby Laboratories by 527.8% during the 4th quarter. Hantz Financial Services Inc. now owns 2,210 shares of the electronics maker’s stock valued at $142,000 after acquiring an additional 1,858 shares in the last quarter. Jefferies Financial Group Inc. acquired a new position in shares of Dolby Laboratories during the 4th quarter valued at $258,000. Partners Group Holding AG acquired a new position in shares of Dolby Laboratories during the 4th quarter valued at $585,000. Covestor Ltd increased its position in shares of Dolby Laboratories by 6.0% during the 4th quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock valued at $198,000 after purchasing an additional 175 shares during the period. Finally, PNC Financial Services Group Inc. increased its position in shares of Dolby Laboratories by 17.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,352 shares of the electronics maker’s stock valued at $408,000 after purchasing an additional 931 shares during the period. Institutional investors own 58.56% of the company’s stock.
Analyst Ratings Changes
Several brokerages have recently issued reports on DLB. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Barrington Research restated an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a report on Monday, April 27th. Finally, Rosenblatt Securities restated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a report on Friday, January 30th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $90.75.
Insider Activity
In related news, CFO Robert J. Park sold 4,895 shares of Dolby Laboratories stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total transaction of $277,448.60. Following the completion of the sale, the chief financial officer owned 81,490 shares of the company’s stock, valued at approximately $4,618,853.20. This trade represents a 5.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP John D. Couling sold 7,666 shares of Dolby Laboratories stock in a transaction on Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total value of $441,178.30. Following the sale, the senior vice president directly owned 118,353 shares of the company’s stock, valued at approximately $6,811,215.15. The trade was a 6.08% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 20,249 shares of company stock worth $1,157,434. 37.93% of the stock is owned by corporate insiders.
Dolby Laboratories Trading Up 3.5%
Shares of DLB stock opened at $56.64 on Wednesday. Dolby Laboratories has a 1-year low of $52.45 and a 1-year high of $77.00. The company has a market capitalization of $5.36 billion, a price-to-earnings ratio of 22.39 and a beta of 0.86. The stock’s fifty day simple moving average is $59.79 and its 200-day simple moving average is $63.20.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. During the same quarter in the previous year, the company posted $1.34 earnings per share. Dolby Laboratories’s revenue for the quarter was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, sell-side analysts predict that Dolby Laboratories will post 3.22 EPS for the current year.
Dolby Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were issued a dividend of $0.36 per share. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.5%. Dolby Laboratories’s payout ratio is currently 56.92%.
Dolby Laboratories Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading
- Five stocks we like better than Dolby Laboratories
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
